Literature DB >> 29613852

Pulmonary infection of cystic fibrosis mice with Staphylococcus aureus requires expression of α-toxin.

Simone Keitsch1, Joachim Riethmüller2, Matthias Soddemann1, Carolin Sehl1, Barbara Wilker1, Michael J Edwards3, Charles C Caldwell3, Martin Fraunholz4, Erich Gulbins1,3, Katrin Anne Becker1.   

Abstract

Pulmonary infections of cystic fibrosis (CF) patients with Staphylococcus aureus (S. aureus) occur very early in the disease. The molecular details that cause infection-susceptibility of CF patients to and mediate infection with S. aureus are poorly characterized. Therefore, we aimed to identify the role of α-toxin, a major S. aureus toxin, for pulmonary infection of CF mice. Infection with S. aureus JE2 resulted in severe pneumonia in CF mice, while wildtype mice were almost unaffected. Deficiency of α-toxin in JE2-Δhla reduced the pathogenicity of S. aureus in CF mice. However, CF mice were still more susceptible to the mutant S. aureus strain than wildtype mice. The S. aureus JE2 induced a marked increase of ceramide and a downregulation of sphingosine and acid ceramidase expression in bronchi of CF mice. Deletion of α-toxin reduced these changes after infection of CF mice. Similar changes were observed in wildtype mice, but at much lower levels. Our data indicate that expression of α-toxin is a major factor causing S. aureus infections in CF mice. Wildtype S. aureus induces a marked increase of ceramide and a reduction of sphingosine and acid ceramidase expression in bronchial epithelial cells of wildtype and CF mice, changes that determine infection susceptibility.

Entities:  

Keywords:  Staphylococcus aureus; ceramide; cystic fibrosis; pneumonia; sphingosine; toxins

Mesh:

Substances:

Year:  2018        PMID: 29613852     DOI: 10.1515/hsz-2018-0161

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  7 in total

Review 1.  Underscoring interstrain variability and the impact of growth conditions on associated antimicrobial susceptibilities in preclinical testing of novel antimicrobial drugs.

Authors:  David A Sanchez; Luis R Martinez
Journal:  Crit Rev Microbiol       Date:  2018-12-06       Impact factor: 7.624

2.  Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies.

Authors:  Murad Abusukhun; Martin S Winkler; Stefan Pöhlmann; Onnen Moerer; Konrad Meissner; Björn Tampe; Heike Hofmann-Winkler; Michael Bauer; Markus H Gräler; Ralf A Claus
Journal:  Front Immunol       Date:  2021-12-20       Impact factor: 7.561

Review 3.  Interaction of host and Staphylococcus aureus protease-system regulates virulence and pathogenicity.

Authors:  Vigyasa Singh; Ujjal Jyoti Phukan
Journal:  Med Microbiol Immunol       Date:  2018-11-27       Impact factor: 3.402

Review 4.  Elusive Roles of the Different Ceramidases in Human Health, Pathophysiology, and Tissue Regeneration.

Authors:  Carolina Duarte; Juliet Akkaoui; Chiaki Yamada; Anny Ho; Cungui Mao; Alexandru Movila
Journal:  Cells       Date:  2020-06-02       Impact factor: 6.600

5.  Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.

Authors:  Eryn E Bernardy; Robert A Petit; Vishnu Raghuram; Ashley M Alexander; Timothy D Read; Joanna B Goldberg
Journal:  mBio       Date:  2020-06-23       Impact factor: 7.867

6.  High Prevalence of Staphylococcus aureus Enterotoxin Gene Cluster Superantigens in Cystic Fibrosis Clinical Isolates.

Authors:  Anthony J Fischer; Samuel H Kilgore; Sachinkumar B Singh; Patrick D Allen; Alexis R Hansen; Dominique H Limoli; Patrick M Schlievert
Journal:  Genes (Basel)       Date:  2019-12-12       Impact factor: 4.096

Review 7.  A Comprehensive Review on the Manipulation of the Sphingolipid Pathway by Pathogenic Bacteria.

Authors:  Monica Rolando; Carmen Buchrieser
Journal:  Front Cell Dev Biol       Date:  2019-08-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.